In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand Eczema. Join Drs. Raj Chovatja and Melinda Gooderham, experts in dermatology in this presentation on chronic hand eczema #CHE. #PeerVoice #meded #dermatology #eczema https://lnkd.in/edbP2Q-b
PeerVoice
Fournisseurs d’apprentissage en ligne
Our mission is to facilitate the rapid adoption of science into global clinical practice, to improve patient outcomes
À propos
PeerVoice delivers independent medical education that strengthens the knowledge and clinical competence of global healthcare professionals. For 20 years, we have designed innovative, expert-led programmes around the unmet educational needs of the medical community. Our activities turn key scientific data and medical perspectives into concise, practical learning that supports evidence-based clinical decisions and better patient care. Delivered across multiple formats and languages, PeerVoice education is designed for busy professionals and can be accessed anytime, anywhere and on any device through a proven platform they trust. Through our extensive global network, PeerVoice activities reach millions of practising physicians, empowering them to apply new knowledge, advance their clinical practice and improve outcomes for patients. Learn more at www.peervoice.com.
- Site web
-
http://www.peervoice.com/
Lien externe pour PeerVoice
- Secteur
- Fournisseurs d’apprentissage en ligne
- Taille de l’entreprise
- 51-200 employés
- Siège social
- Amsterdam
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2007
- Domaines
- Elearning, Continuing Medical Education (CME), Independent Medical Education (IME), Follow @PeerVoice on X, Live Symposia, Continuing Professional Development (CPD) , Global Medical Education, Medical Writing , Instructional Design, Outcomes Analysis, Education Strategy et Project Management
Lieux
Employés chez PeerVoice
Nouvelles
-
PeerVoice a republié ceci
Continuous education drives better stroke care. We are pleased to support this PeerVoice educational activity, which brings together expert insights into the evolving evidence on investigational Factor XIa inhibition for secondary stroke prevention. WATCH NOW: https://lnkd.in/en2aSJju #Stroke #StrokePrevention #FXIa #Neurology #MedEd PeerVoice
WATCH NOW: https://lnkd.in/eMh7mden On-Demand: Assessing the Potential of Factor XIa Inhibition for Secondary Stroke Prevention Missed our recent live event in Paris? Join a multidisciplinary panel of experts as they examine investigational FXIa inhibition for secondary stroke prevention, including: • The balance between thrombosis prevention and haemostasis • Phase 3 efficacy and safety evidence alongside antiplatelet therapy • How patient characteristics may inform the clinical relevance of the findings • Implications for collaboration across the stroke care team Earn CE credit and explore the evolving evidence in secondary stroke prevention. This PeerVoice CE-accredited activity has been endorsed by European Stroke Organisation (ESO). #SecondaryStrokePrevention #IschaemicStroke #FXIa #Neurology #Haematology #CE #PeerVoice #MedEd
-
-
WATCH NOW: https://lnkd.in/eMh7mden On-Demand: Assessing the Potential of Factor XIa Inhibition for Secondary Stroke Prevention Missed our recent live event in Paris? Join a multidisciplinary panel of experts as they examine investigational FXIa inhibition for secondary stroke prevention, including: • The balance between thrombosis prevention and haemostasis • Phase 3 efficacy and safety evidence alongside antiplatelet therapy • How patient characteristics may inform the clinical relevance of the findings • Implications for collaboration across the stroke care team Earn CE credit and explore the evolving evidence in secondary stroke prevention. This PeerVoice CE-accredited activity has been endorsed by European Stroke Organisation (ESO). #SecondaryStrokePrevention #IschaemicStroke #FXIa #Neurology #Haematology #CE #PeerVoice #MedEd
-
-
!!!Today is the day!!! - join this CE-accredited virtual live event: https://lnkd.in/en9uhvVE Follow Eric Van Cutsem, Florian Lordick, MD, FESMO, and Lorenza Rimassa as they discuss the practical integration of #HER2-directed therapies across biliary tract, colorectal, and gastric cancers. Through expert discussion, the faculty will cover testing strategies, treatment sequencing, as well as timely transition across lines of therapy. ⏰ 5:00–6:00 PM CEST
-
-
Only 3 days to go - register now https://lnkd.in/en9uhvVE for this #CE-accredited virtual live event on Monday. Join Eric Van Cutsem, Florian Lordick, MD, FESMO and Lorenza Rimassa as they discuss the practical integration of #HER2-directed therapies across biliary tract, colorectal, and gastric cancers. 📅 Monday, 3 August 2026 ⏰ 5:00–6:00 PM CEST 💻 Virtual Live Event
-
-
PeerVoice a republié ceci
What's better than a ristretto on a monday morning? A ristretto on a "neuroimmunology matters" coaster. A team member gave me these today as a farewell present. No marketing department involved. Just a super brillant idea. Which is exactly why it works. And it says "powered by Heinz Wiendl and Team." The second part is the one that counts. Science is usually measured in papers, grants and conferences – but it is carried by people who, even on a Monday at 7 am, believe that neuroimmunology matters. Now my coffee literally stands on it. You can't mandate team culture. You recognize it in moments like this. And if neuroimmunology matters to you too: join the club. > the ISNI International Society of Neuroimmunology (ISNI) is the global home of our field – membership is currently open with dues waived for 2026, and the 18th ISNI Congress takes place in Venice, October 2027. > there is a very interesting list of membership value package elements, → https://www.isniweb.org > PeerVoice has established an initiative called "Neuroimmunology matters" /https://lnkd.in/dyFkKH5V) with online medical eduction across all disciplines of neuroimmunology > Universitätsklinikum Freiburg Department of Neurology announces Neuroimmunology fellowships as part of the #Neuroimmunologycompetencenetwork (https://lnkd.in/dMGBR-Ek). Applications open soon! Dr. Vera Roedel Heinz Wiendl Prof. Valmed® ISNI International Society of Neuroimmunology Fabienne Brilot Caitriona Forde
-
-
WATCH NOW: https://lnkd.in/esZXkyVy Acute hepatic porphyria (AHP) is frequently under-recognised and misdiagnosed across multiple different healthcare settings. Delays in diagnosis can lead to repeated attacks, cumulative neurological damage, and chronic health issues such as kidney disease and hypertension. In this activity, multidisciplinary experts explore the importance of suspecting and testing for AHP early in patients with indicative clinical symptoms and signs. #PeerVoice #AHP #acutehepaticporphyria #raredisease #hepatology #gastroenterology #neurology #gynaecology #psychiatry #haematology #MedicalEducation
-
-
REGISTER NOW: https://lnkd.in/en9uhvVE Join Eric Van Cutsem, Florian Lordick, MD, PhD, and Lorenza Rimassa for this CE-accredited virtual live event as they explore practical integration of HER2-directed therapies across biliary tract, colorectal and gastric cancers. Through expert discussion, the faculty will cover testing strategies, treatment sequencing, as well as timely transition across lines of therapy. 📅 Monday, 3 August 2026 ⏰ 5:00–6:00 PM CEST 💻 Virtual Live Event #HER2 #GastrointestinalCancer #Oncology
-
-
Did you miss our event in Paris, at #ISTH2026? You can watch the replay here: https://lnkd.in/gP4SjS9y Stay tuned! The OnDemand version will soon be available in our #SecondaryStrokePrevention curriculum: https://lnkd.in/gDekFr74 #CME #PeerVoice #Stroke #SSP
-
-
Transplant nephrologist Dr John Friedewald discusses key evidence and insights emerging from the recent transplant congress in Boston. #PeerVoice #KidneyTransplant #KidneyTransplantation #transplantsurgery #nephrology #surgery #ATC2026 https://lnkd.in/gvfPDi7h
-